☆ 4.7 Letter

Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients

CRITICAL CARE (2023)

Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction

Gabriel Jakobsson et al.

Summary: This study revealed the association between elevated plasma S100A8/A9 levels and left ventricle dysfunction in severe sepsis patients, and demonstrated the potential therapeutic effects of pharmacological blockade of S100A8/A9 in mitigating myocardial dysfunction.

CRITICAL CARE (2023)

添加到收藏夹

Article Critical Care Medicine

A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit

Esther Peters et al.

CRITICAL CARE (2018)

添加到收藏夹

Letter Hematology

Evaluating Sepsis during Continuous Dialysis: Are Biomarkers Still Valid?

Patrick M. Honore et al.

BLOOD PURIFICATION (2014)

添加到收藏夹

Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients

相关参考文献

Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction

A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit

Evaluating Sepsis during Continuous Dialysis: Are Biomarkers Still Valid?

导出引文

分享论文